Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice

The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease progression of Alzheimer's disease (AD) for patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodes, John F., Oakley, Carlee I., O'Keefe, James H., Lu, Peilin, Galvin, James E., Saif, Nabeel, Bellara, Sonia, Rahman, Aneela, Kaufman, Yakir, Hristov, Hollie, Rajji, Tarek K., Fosnacht Morgan, Anne Marie, Patel, Smita, Merrill, David A., Kaiser, Scott, Meléndez-Cabrero, Josefina, Melendez, Juan A., Krikorian, Robert, Isaacson, Richard S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348710/
https://www.ncbi.nlm.nih.gov/pubmed/30719021
http://dx.doi.org/10.3389/fneur.2018.01179
_version_ 1783390151429324800
author Hodes, John F.
Oakley, Carlee I.
O'Keefe, James H.
Lu, Peilin
Galvin, James E.
Saif, Nabeel
Bellara, Sonia
Rahman, Aneela
Kaufman, Yakir
Hristov, Hollie
Rajji, Tarek K.
Fosnacht Morgan, Anne Marie
Patel, Smita
Merrill, David A.
Kaiser, Scott
Meléndez-Cabrero, Josefina
Melendez, Juan A.
Krikorian, Robert
Isaacson, Richard S.
author_facet Hodes, John F.
Oakley, Carlee I.
O'Keefe, James H.
Lu, Peilin
Galvin, James E.
Saif, Nabeel
Bellara, Sonia
Rahman, Aneela
Kaufman, Yakir
Hristov, Hollie
Rajji, Tarek K.
Fosnacht Morgan, Anne Marie
Patel, Smita
Merrill, David A.
Kaiser, Scott
Meléndez-Cabrero, Josefina
Melendez, Juan A.
Krikorian, Robert
Isaacson, Richard S.
author_sort Hodes, John F.
collection PubMed
description The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease progression of Alzheimer's disease (AD) for patients seeking clinical care. Furthermore, it is important to distinguish between Alzheimer's disease prevention and Alzheimer's dementia prevention when using these terms. While prior studies have codified research-based criteria for the progressive stages of AD, there are no clear clinical consensus criteria to guide the use of these terms for physicians in practice. A clear understanding of the implications of each term will help guide clinical practice and clinical research. The authors explore the semantics and appropriate use of the terms “prevention” and “risk reduction” as they relate to AD in clinical practice.
format Online
Article
Text
id pubmed-6348710
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63487102019-02-04 Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice Hodes, John F. Oakley, Carlee I. O'Keefe, James H. Lu, Peilin Galvin, James E. Saif, Nabeel Bellara, Sonia Rahman, Aneela Kaufman, Yakir Hristov, Hollie Rajji, Tarek K. Fosnacht Morgan, Anne Marie Patel, Smita Merrill, David A. Kaiser, Scott Meléndez-Cabrero, Josefina Melendez, Juan A. Krikorian, Robert Isaacson, Richard S. Front Neurol Neurology The terms “prevention” and “risk reduction” are often used interchangeably in medicine. There is considerable debate, however, over the use of these terms in describing interventions that aim to preserve cognitive health and/or delay disease progression of Alzheimer's disease (AD) for patients seeking clinical care. Furthermore, it is important to distinguish between Alzheimer's disease prevention and Alzheimer's dementia prevention when using these terms. While prior studies have codified research-based criteria for the progressive stages of AD, there are no clear clinical consensus criteria to guide the use of these terms for physicians in practice. A clear understanding of the implications of each term will help guide clinical practice and clinical research. The authors explore the semantics and appropriate use of the terms “prevention” and “risk reduction” as they relate to AD in clinical practice. Frontiers Media S.A. 2019-01-21 /pmc/articles/PMC6348710/ /pubmed/30719021 http://dx.doi.org/10.3389/fneur.2018.01179 Text en Copyright © 2019 Hodes, Oakley, O'Keefe, Lu, Galvin, Saif, Bellara, Rahman, Kaufman, Hristov, Rajji, Fosnacht Morgan, Patel, Merrill, Kaiser, Meléndez-Cabrero, Melendez, Krikorian and Isaacson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Hodes, John F.
Oakley, Carlee I.
O'Keefe, James H.
Lu, Peilin
Galvin, James E.
Saif, Nabeel
Bellara, Sonia
Rahman, Aneela
Kaufman, Yakir
Hristov, Hollie
Rajji, Tarek K.
Fosnacht Morgan, Anne Marie
Patel, Smita
Merrill, David A.
Kaiser, Scott
Meléndez-Cabrero, Josefina
Melendez, Juan A.
Krikorian, Robert
Isaacson, Richard S.
Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
title Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
title_full Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
title_fullStr Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
title_full_unstemmed Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
title_short Alzheimer's “Prevention” vs. “Risk Reduction”: Transcending Semantics for Clinical Practice
title_sort alzheimer's “prevention” vs. “risk reduction”: transcending semantics for clinical practice
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348710/
https://www.ncbi.nlm.nih.gov/pubmed/30719021
http://dx.doi.org/10.3389/fneur.2018.01179
work_keys_str_mv AT hodesjohnf alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT oakleycarleei alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT okeefejamesh alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT lupeilin alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT galvinjamese alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT saifnabeel alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT bellarasonia alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT rahmananeela alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT kaufmanyakir alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT hristovhollie alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT rajjitarekk alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT fosnachtmorganannemarie alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT patelsmita alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT merrilldavida alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT kaiserscott alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT melendezcabrerojosefina alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT melendezjuana alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT krikorianrobert alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice
AT isaacsonrichards alzheimerspreventionvsriskreductiontranscendingsemanticsforclinicalpractice